Neuraxis Inc. Common Stock (NRXS)

About NRXS

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and as…

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Employees

24

Website

neuraxis.com/

Fundamentals

1-day range

$5.95$6.11

Market cap

$86.47M

P/E (trailing)

—

P/E (forward)

-22.22

EPS (trailing)

$-0.73

Dividend yield

—

Beta

1.48

Avg. volume

95.0K

Forecasts

2 analyst ratings

Neuraxis Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• NRXS

  Neuraxis Inc. Common Stock

  $5.98

  ▼ 0.66%
  Market cap $86.47MP/E —
  $2.21$9.33
• OM

  Outset Medical Inc. Common Stock

  $3.93

  ▼ 4.03%
  Market cap $96.39MP/E —
  $3$16.16
• HYPR

  Hyperfine Inc. Class A Common Stock

  $0.8358

  ▼ 1.09%
  Market cap $97.48MP/E —
• STEX

  Streamex Corp. Common Stock

  $0.7649

  ▼ 7.51%
  Market cap $75.35MP/E —
  $0.6552$7.44
• HSDT

  Solana Company Class A Common Stock (DE)

  $2.34

  ▼ 3.70%
  Market cap $98.09MP/E —
  $1.19$25.5
• POCI

  Precision Optics Corporation Inc. Common stock

  $4.41

  ▼ 0.45%
  Market cap $46.41MP/E —
  $3.55$6.15
• QTI

  QT Imaging Holdings Inc. Common Stock

  $3.09

  ▼ 0.96%
  Market cap $37.38MP/E —
  $2.62$19.05

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• NeurAxis, Inc. (NRXS) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/11/2026
• Neuraxis Q2 EPS $(0.19) Beats $(0.32) Estimate, Sales $1.929M Miss $2.000M Estimate
  benzinga · 8/11/2026
• Neuraxis Q2 EPS $(0.19) Beats $(0.32) Estimate, Sales $1.929M Miss $2.000M Estimate
  Benzinga · 8/11/2026
• 12 Health Care Stocks Moving In Monday's Pre-Market Session
  Benzinga · 8/3/2026

• Gil Aharon · April 28, 2026 · Grant

  221.9K
• Gil Aharon · April 28, 2026 · Grant

  12.3K
• Timothy Robert Henrichs · April 1, 2026 · Buy

  7.6K @ $1.96
• Brian Allen Carrico · April 1, 2026 · Buy

  8.1K @ $1.96
• Thomas Joeseph Carrico · April 1, 2026 · Buy

  667 @ $1.96

Institutional Ownership

March 31, 2026

Total shares held

1.99M

Total value held

$14.21M

Institutional holders

25